
|Articles|December 3, 2018
Novel treatments in pipeline for diabetic eye disease
Patrik De Haes, MD, CEO of Oxurion NV, shares the latest updates in clinical studies at the OIS@AAO meeting in Chicago, Oct. 2018.
Advertisement
Patrik De Haes, MD, CEO of Oxurion NV, shares the latest updates in clinical studies at the OIS@AAO meeting in Chicago, Oct. 2018.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
MacTel masquerades: How to spot what others miss
2
Preclinical study explores contact lens–based neuromodulation for depression
3
QA102 data suggest signal in intermediate dry AMD, but insignificant drusen volume change
4
Avacincaptad pegol analysis links GA treatment to preserved driving vision
5























